Imelda General Hospital

At Imelda General Hospital in Putte, Belgium, clinical research in these areas focuses on understanding and reducing the burden of atherosclerotic cardiovascular disease while also addressing metabolic health concerns linked to obesity and overweight.

• Studies of elevated Lp(a) and its role in cardiovascular risk
• Research on treatments aimed at improving body weight in people with persistent obesity

These trials are designed to evaluate whether new therapies can improve outcomes, lower future cardiovascular events, and support better weight management for patients.

This research stream examines nutritional and metabolic diseases, with a strong emphasis on persistent obesity and overweight. The goal is to test whether new treatment approaches can produce meaningful changes in body weight and improve overall metabolic health.

• Evaluation of therapies for persistent obesity
• Clinical interest in improving outcomes for people with overweight

The work supports better care for patients who need effective, practical options for long-term weight reduction and related health benefits.

Another key area at this site is the study of cardiovascular diseases, especially in adults with elevated lipoprotein(a). Research here is focused on determining whether new therapies can reduce the likelihood of major adverse cardiovascular events and improve prevention strategies.

• Investigation of atherosclerotic cardiovascular disease
• Trials exploring ways to lower major cardiovascular events

These studies aim to strengthen risk reduction efforts for patients who remain vulnerable despite current care.